MedTrace Logo

Autoantibodies in Breast Cancer Detection

NCT03623945 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1279

Last updated 2024-12-11

No results posted yet for this study

Summary

Prospective, single-center study in women who have recently had an abnormal mammogram followed by a breast biopsy or women who have recently had a normal screening mammogram. We are no longer enrolling women who had normal Screening mammograms.

Conditions

Interventions

OTHER

Collection of blood

Collection of blood only to look at circulating autoantibodies that recognize breast cancer proteins to potentially be used as a biosensor for identifying patients with increased risk of having breast cancer

Sponsors & Collaborators

  • Inanovate

    collaborator UNKNOWN

  • Sanford Health

    lead OTHER

Principal Investigators

  • Allison Watson, MD · Sanford Health

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-24
Primary Completion
2024-03-11
Completion
2024-03-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03623945 on ClinicalTrials.gov